• QRICH1 Drives HBV-Induced HMGB1 Secretion and Hepatic Fibros

  2026-05-12

  This study identifies QRICH1 as a key effector of endoplasmic reticulum (ER) stress that amplifies hepatitis B virus (HBV)-mediated HMGB1 translocation and secretion in hepatocytes. These findings clarify the molecular crosstalk between ER stress, QRICH1, and HMGB1 in hepatic fibrosis, providing new mechanistic insight relevant for liver disease research.

• Novel PDK4 Inhibitors: Advances for Metabolic Disease Resear

  2026-05-12

  This article reviews a recent study identifying a new class of pyruvate dehydrogenase kinase 4 (PDK4) inhibitors with promising oral efficacy for metabolic diseases. The research details structural innovation, in vitro and in vivo validation, and offers implications for future therapeutic development.

• Honokiol-Induced Paraptosis in APL: Role of mTOR and MAPK Si

  2026-05-11

  This study demonstrates that honokiol induces paraptosis-like cell death in acute promyelocytic leukemia (APL) cells through activation of mTOR and MAPK pathways. The findings highlight a nonapoptotic, caspase-independent mechanism involving ER stress and proteasome inhibition, providing new avenues for therapeutic intervention in APL resistant to conventional treatments.

• Entinostat (MS-275): Applied Protocols in Cancer Cell Analys

  2026-05-11

  Entinostat (MS-275) enables selective HDAC1/3 inhibition for robust cancer cell proliferation assays and apoptosis studies. This guide translates reference-backed methods and troubleshooting strategies into actionable, stepwise workflows using APExBIO’s trusted reagent.

• CF10 and EdU Synergy Drives Telomere Attrition in CRC Models

  2026-05-10

  This study demonstrates that the fluoropyrimidine polymer CF10 synergizes with 5-ethynyl-2′-deoxyuridine (EdU) to induce telomere attrition and mitotic catastrophe in colorectal cancer cells. The findings offer mechanistic insight into how DNA-targeting combinations can enhance telomerase-targeted strategies and inform future research on telomerase inhibitors in oncology.

• Inducing Dormancy in Mammalian Embryos via mTOR Inhibition

  2026-05-09

  This protocol-driven study establishes a robust and reversible in vitro method for inducing a diapause-like dormant state in mammalian embryonic cells by pharmacologically inhibiting mTOR. The approach offers a noninvasive, scalable alternative to traditional surgical models, enabling high-throughput investigation of developmental dormancy and expanding research capabilities in assisted reproductive technologies.

• Translating mRNA Mechanisms to Reliable Reporter Assays

  2026-05-09

  This article provides translational researchers with mechanistic insight and practical guidance for leveraging ARCA EGFP mRNA (5-moUTP) as a next-generation, polyadenylated reporter for fluorescence-based transfection control. It contextualizes advances in mRNA engineering, storage, and immune evasion, while bridging recent literature with strategic recommendations for robust, reproducible results.

• Nanoplastics and Cadmium Trigger Apoptosis via IP3R/Ca2+/STA

  2026-05-08

  This study demonstrates that co-exposure to polystyrene nanoplastics and cadmium induces pronounced apoptosis in intestinal cells, mediated by the IP3R/Ca2+/STAT3 pathway. The work advances understanding of environmental contaminant synergy and highlights the utility of calcium chelation for dissecting complex cell signaling events.

• Gepotidacin in Antibacterial Research: Applied Protocols and

  2026-05-07

  Gepotidacin (GSK2140944) is reshaping antibacterial research with its unique dual topoisomerase inhibition, offering powerful solutions against resistant pathogens. This article translates the latest clinical and experimental findings into actionable workflows, optimization tips, and troubleshooting strategies for maximizing data quality in bacterial DNA replication inhibition studies.

• UBR1 and UBR2: Key ER Stress Sensors in Mammalian PQC

  2026-05-07

  This study identifies the E3 ligases UBR1 and UBR2 as central sensors of endoplasmic reticulum (ER) stress in mammals, directly linking the N-degron pathway to ER-associated protein quality control (PQC). The findings deepen understanding of ER stress response mechanisms and have practical implications for modeling ER stress and apoptosis in disease research.

• AG-490 (Tyrphostin B42): Applied Workflows in Cancer and Imm

  2026-05-06

  AG-490 (Tyrphostin B42) empowers researchers to dissect JAK2/STAT and MAPK pathways with precision, enabling robust modeling of immune polarization and tumor signaling. This guide delivers actionable protocols, troubleshooting insights, and practical recommendations grounded in the latest exosome-mediated macrophage polarization research.

• Red Blood Cell Lysis Buffer: Precision in Erythrocyte Remova

  2026-05-06

  APExBIO's Red Blood Cell Lysis Buffer empowers researchers with selective erythrocyte lysis, preserving nucleated cells for high-fidelity downstream assays. Explore optimized protocols, troubleshooting insights, and real-world workflow enhancements that elevate blood sample preparation in translational and molecular research.

• STING agonist-1: Enabling Precision STING Pathway Activation

  2026-05-05

  STING agonist-1 empowers researchers to dissect innate immunity by delivering robust, reproducible STING pathway activation. Its high purity and DMSO-solubility streamline B cell and tertiary lymphoid structure studies, with proven relevance in cancer immunology workflows.

• 2′-O-Galloylhyperin as a TSHR Antagonist in Thyroid Eye Dise

  2026-05-05

  A recent study identifies 2′-O-galloylhyperin as an FDA-approved drug that inhibits thyrotropin receptor (TSHR) activity, thereby preventing tissue remodeling in thyroid eye disease (TED). This work highlights the potential of structure-based virtual screening of FDA-approved compound libraries for therapeutically relevant target identification in fibroblast-driven pathologies.

• Hematoxylin and Eosin Staining Kit: Protocol and Troubleshoo

  2026-05-04

  The Hematoxylin and Eosin Staining Kit (SKU: K1142) provides a ready-to-use solution set for reliable cellular and tissue morphology visualization in research environments. It is ideally suited for paraffin and frozen tissue section staining, as well as cytological preparations, but is not intended for clinical diagnosis or medical applications. Researchers benefit from standardized nuclear and cytoplasmic staining while minimizing workflow variability.

445 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page